Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Royaume-Uni (3)
Advocacy (policy advocacy, lobbying)
Across all conditions/Other (1)
Research Funder (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Continuity and sustainability
Clinical study phase I